Physician profile
Christi D Menges
NPI 1346442332
$1,105.88
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.54 · 2020: $34.53 · 2021: $181 · 2022: $279 · 2023: $506 · 2024: $93.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $486.05 |
| Education | $113.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $204.41 | 2022-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $150.42 | 2021-2023 | |
| Intuitive Surgical, INC. | $142.15 | 2023 | Da Vinci Surgical System |
| Mayne Pharma Commercial LLC | $78.01 | 2021-2024 | |
| Hologic Sales and Service, LLC | $68.31 | 2022-2023 | Aptima, Third Wave, Thinprep 2000 Processor |
| Organon LLC | $57.80 | 2023-2024 | Nexplanon |
| Aspira Women'S Health INC | $56.77 | 2021-2022 | |
| Virtus Pharmaceuticals LLC | $48.05 | 2021 | |
| Agile Therapeutics, INC. | $33.88 | 2023-2024 | Twirla |
| Pfizer INC. | $30.56 | 2023 | |
| Glaxosmithkline, LLC. | $30.55 | 2020-2021 | |
| Allergan, INC. | $26.11 | 2022 | |
| Exeltis, USA INC. | $24.35 | 2023 | Slynd |
| Amgen INC. | $21.74 | 2020 | |
| Medtronic, INC. | $19.87 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $19.14 | 2022 | |
| Myovant Sciences INC. | $17.81 | 2022 | |
| Ibsa Pharma INC. | $15.92 | 2022 | |
| Therapeuticsmd, INC. | $13.48 | 2021 | |
| Millicent US INC | $13.35 | 2024 | |
| Lupin INC. | $12.66 | 2021 | |
| Aesculap, INC. | $12.54 | 2019 | |
| Meditrina | $8.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christi Menges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.